These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21371152)

  • 1. Commentary on Halpern et al. (2011): strengthening the case against functionally significant serotonergic neurotoxicity in human MDMA (ecstasy) users.
    Lyvers M
    Addiction; 2011 Apr; 106(4):787-8. PubMed ID: 21371152
    [No Abstract]   [Full Text] [Related]  

  • 2. Residual neurocognitive features of ecstasy use: a re-interpretation of Halpern et al. (2011) consistent with serotonergic neurotoxicity.
    Parrott AC
    Addiction; 2011 Jul; 106(7):1365-8; author reply 1370-2. PubMed ID: 21635601
    [No Abstract]   [Full Text] [Related]  

  • 3. [Psychiatric and cognitive long-term effects of ecstasy].
    Høiseth G; Løvåsdal Ø; Titze TK; Bramness JG; Bachs L
    Tidsskr Nor Laegeforen; 2006 Feb; 126(5):596-8. PubMed ID: 16505868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ; McFie L; Fleetwood H; Robinson JA
    Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuropsychiatric disorders induced by MDMA ("Ecstasy")].
    Bailly D
    Encephale; 1999; 25(6):595-602. PubMed ID: 10668603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal remodelling after MDMA neurotoxicity: a single case study.
    Nifosì F; Martinuzzi A; Toffanin T; Costanzo R; Vestri A; Battaglia M; Bertagnoni GE; Lupi A; Amistà P; Carollo C; Perini G
    World J Biol Psychiatry; 2009; 10(4 Pt 3):961-8. PubMed ID: 18609419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of MDMA (ecstasy) use and neurotoxicity.
    Franken IH
    Eur Psychiatry; 2001 Dec; 16(8):508-9. PubMed ID: 11777745
    [No Abstract]   [Full Text] [Related]  

  • 9. Involvement of free radicals in MDMA-induced neurotoxicity in mice.
    Cadet JL; Thiriet N; Jayanthi S
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS57-9. PubMed ID: 11435997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical crossroads for MDMA.
    Guillot C
    J Psychoactive Drugs; 2005 Dec; 37(4):445-7. PubMed ID: 16480172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?
    Kish SJ
    Pharmacol Biochem Behav; 2002 Apr; 71(4):845-55. PubMed ID: 11888575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E; Daumann J
    Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ecstasy is a dangerous drug the society chooses to ignore].
    Heilig M
    Lakartidningen; 2003 Feb; 100(9):688-90. PubMed ID: 12674555
    [No Abstract]   [Full Text] [Related]  

  • 14. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
    Gouzoulis-Mayfrank E; Fischermann T; Rezk M; Thimm B; Hensen G; Daumann J
    Drug Alcohol Depend; 2005 Jun; 78(3):317-23. PubMed ID: 15893163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity.
    Parrott AC
    Pharmacol Biochem Behav; 2002 Apr; 71(4):837-44. PubMed ID: 11888574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is the anxiety about Ecstasy justified?].
    Möller-Nehring E; Luderer HJ
    Fortschr Med; 1997 Mar; 115(7):28, 31-2, 34. PubMed ID: 9173018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response.
    Green AR; O'shea E; Colado MI
    Eur J Pharmacol; 2004 Oct; 500(1-3):3-13. PubMed ID: 15464016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment on Halpern et al. (2011).
    Fisk JE; Murphy PN; Montgomery C; Wareing M
    Addiction; 2011 Jul; 106(7):1368-9; author reply 1370-2. PubMed ID: 21635597
    [No Abstract]   [Full Text] [Related]  

  • 19. Recreational ecstasy use and depression.
    Guillot C; Greenway D
    J Psychopharmacol; 2006 May; 20(3):411-6. PubMed ID: 16574715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDMA and 5-HT neurotoxicity: the empirical evidence for its adverse effects in humans - no need for translation.
    Parrott AC
    Br J Pharmacol; 2012 Jul; 166(5):1518-20; discussion 1521-2. PubMed ID: 22404300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.